US20100204677A1 - Patient hydration system and method - Google Patents
Patient hydration system and method Download PDFInfo
- Publication number
- US20100204677A1 US20100204677A1 US12/798,940 US79894010A US2010204677A1 US 20100204677 A1 US20100204677 A1 US 20100204677A1 US 79894010 A US79894010 A US 79894010A US 2010204677 A1 US2010204677 A1 US 2010204677A1
- Authority
- US
- United States
- Prior art keywords
- patient
- fluid
- urine
- console
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/201—Assessing renal or kidney functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/207—Sensing devices adapted to collect urine
- A61B5/208—Sensing devices adapted to collect urine adapted to determine urine quantity, e.g. flow, volume
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/007—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16886—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body for measuring fluid flow rate, i.e. flowmeters
- A61M5/16895—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body for measuring fluid flow rate, i.e. flowmeters by monitoring weight change, e.g. of infusion container
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/36—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests with means for eliminating or preventing injection or infusion of air into body
- A61M5/365—Air detectors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01G—WEIGHING
- G01G17/00—Apparatus for or methods of weighing material of special form or property
- G01G17/04—Apparatus for or methods of weighing material of special form or property for weighing fluids, e.g. gases, pastes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/18—General characteristics of the apparatus with alarm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3355—Controlling downstream pump pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3379—Masses, volumes, levels of fluids in reservoirs, flow rates
- A61M2205/3393—Masses, volumes, levels of fluids in reservoirs, flow rates by weighing the reservoir
Definitions
- This invention relates to a patient hydration system and method wherein the rate of hydration fluid delivered to the patient is automatically adjusted based on the urine output of the patient to maintain, as necessary, a zero, positive, or negative net fluid balance in the patient.
- RCN radiocontrast nephropathy
- RCN is the third most common cause of hospital-acquired renal failure. It occurs in over 5% of patients with any baseline renal insufficiency and in 50% of patients with preexisting chronic renal insufficiency and diabetes.
- Radiocontrast media has a variety of physiologic effects believed to contribute to the development of RCN.
- One of the main contributors is renal medullary ischemia, which results from a severe, radiocontrast-induced reduction in renal/intrarenal blood flow and oxygen delivery.
- the medullary ischemia induces ischemia and/or death of the metabolically active areas of the medulla responsible for urine formation, called the renal tubules.
- Medullary ischemia is attributed to the increase of oxygen demand by the kidney struggling to remove the radiocontrast media from blood plasma and excrete it from the body at the same time as the normal process of controlling the concentration of urine.
- Oxygen consumption in the medulla of the kidney is directly related to the work of concentrating urine. Since the presence of radiocontrast media in the urine makes it much more difficult for the kidney to concentrate urine, the work of the medulla outstrips the available oxygen supply and leads to medullary ischemia.
- a major limitation to the more widespread use of the already known therapeutic, or optimal, levels of I.V. hydration is the current inability to balance the amount of fluid going into the patient to the amount of fluid being removed or excreted from the patient. It is possible to have a nurse measure a patient's urine output frequently but this method is impractical as nurses are often responsible for the care of many patients.
- the only accurate method of measuring urine output is to place a catheter into the patient's urinary bladder. Without a catheter, the patient must excrete the urine that may have been stored in the bladder for several hours. During this time, the amount of I.V. hydration can be significantly less than the amount of urine produced by the kidneys and stored in the bladder, leading to dehydration. Since patients do not normally have such a catheter during procedures using radiocontrast media, a valid measurement of urine output is not possible.
- hydration therapy is given intravenously (I.V.) when someone is losing necessary fluids at a rate faster than they are retaining fluids.
- I.V. intravenously
- the patient receives the necessary fluids much faster than by drinking them.
- dehydration can be heightened by hyperemesis (vomiting), therefore the I.V. method eliminates the need to take fluids orally.
- An anesthetized or sedated patient may not be able to drink.
- Hydration is used in clinical environments such as surgery, ICU, cathlab, oncology center and many others. At this time, hydration therapy is performed using inflatable pressure bags and/or I.V. pumps.
- a number of I.V. pumps on the market are designed for rapid infusion of fluids (as opposed to slow I.V. drug delivery) for perioperative hydration during surgery, ICU use and even emergency use for fluid resuscitation.
- An infusion pump is a device used in a health care facility to pump fluids into a patient in a controlled manner.
- the device may use a piston pump, a roller pump, or a peristaltic pump and may be powered electrically or mechanically.
- the device may also operate using a constant force to propel the fluid through a narrow tube, which determines the flow rate.
- the device may include means to detect a fault condition, such as air in, or blockage of, the infusion line and to activate an alarm.
- An example of a device for rapid infusion of fluids is the Infusion Dynamics (Plymouth Meeting, Pa.) Power Infuser.
- the Power Infuser uses two alternating syringes as a pumping engine. Since it is only intended to deliver fluids (not medication), the Power Infuser has accuracy of 15%. It provides a convenient way to deliver colloid as well as crystalloid for hydration during the perioperative period among other possible clinical settings.
- the Power Infuser provides anesthesiologists with the ability to infuse at rates similar to that seen with pressure bags, but with more exact volume control.
- the maximum infusion rate is 6 L/hr. It has the flexibility of infusing fluid at 0.2, 1, 2, 4 and 6 L/hr. A bolus setting of 250 mL will deliver that volume in 2.5 min. In a large blood loss surgical case, the use of Power Infuser enables large volumes of colloid to be delivered to restore hemodynamics.
- loop diuretics such as furosemide (frusemide) reduce sodium reabsorption and consequentially reduce oxygen consumption of the kidney. They also reduce concentration of contrast agents in the urine-collecting cavities of the kidney. They induce diuresis (e.g., patient produces large quantities of very dilute urine) and help remove contrast out of the kidney faster. Theoretically, they should be the first line of defense against RCN. In fact, they were used to prevent RCN based on this assumption until clinical evidence suggested that they were actually deleterious. More recently, doubts have been raised regarding the validity of those negative clinical studies.
- furosemide-treated subjects lost 0.7 kg on average, whereas a 1.3-kg weight gain was noted in patients randomized to hydration alone, suggesting that in furosemide-treated subjects the hydration protocol has been insufficient and patients were dehydrated by excessive diuresis.
- diuresis is widely variable and unpredictable but the fluid replacement (hydration) at a constant infusion rate is prescribed in advance.
- fluid is typically given conservatively at 1 ml/hr per kg of body weight.
- the actual effect of diuretic is typically not known for 4 hours (until the sufficient amount of urine is collected and measured) and it is too late and too difficult to correct any imbalance. Meanwhile, patients could be losing fluid at 500 ml/hour while receiving the replacement at only 70 ml/hour.
- the effects of forced diuresis without balancing are illustrated in the research paper by Wakelkamp et. al. “The Influence of Drug input rate on the development of tolerance to furosemide” Br J. Clin. Pharmacol.
- diuresis and natriuresis curves were generated by infusing 10 mg of I.V. furosemide over 10 min to human volunteers. From that paper it can be seen that a patient can lose 1,300 ml of urine within 8 hours following the administration of this potent diuretic. Standard unbalanced I.V. hydration at 75 ml/h will only replace 600 ml in 8 hours. As a result the patient can lose “net” 700 ml of body fluid and become dehydrated. If such patient is vulnerable to renal insult, they can suffer kidney damage.
- the invention results from the realization that radiocontrast nephropathy in particular and patient dehydration in general can be prevented by automatically measuring the urine output of the patient and adjusting the rate of delivery of a hydration fluid to the patient to achieve, as necessary, a zero, positive, or negative net fluid balance in the patient.
- the system typically includes a console for mounting on an IV pole.
- the console includes an input for setting a desired fluid balance for a set therapy duration.
- a first attachment mechanism extends from the console for hanging a urine collection chamber.
- a second attachment mechanism extends from the console for hanging a source of hydration fluid.
- a weighing subsystem in the console is responsive to the first attachment mechanism for weighing the patient's urine output collected in the urine collection chamber and is responsive to the second attachment mechanism for weighing the source of hydration fluid.
- An infusion pump is integrated with the console and configured to pump hydration fluid from the source of hydration fluid into the patient.
- a controller in the console is responsive to the set desired fluid balance, the set therapy duration, and the weighing subsystem.
- the controller is configured to determine the patient's urine output based on the weight of the urine collection chamber, determine the amount of fluid infused into the patient, and control the infusion pump to inject hydration fluid into the patient based on the set desired fluid balance, the weight of the urine collection chamber, and the weight of the source of hydration fluid to achieve the desired fluid balance during the set therapy duration.
- the console may include a display which displays the elapsed time of the therapy duration and the current fluid balance.
- the system may include means for indicating, on the console, when the urine collection is empty.
- the system may include means for indicating, on the console, when the source of hydration fluid is low on fluid.
- the controller may be configured to determine the patient's urine output based on the rate of change of the weight of the urine collection chamber, calculate a desired infusion rate based on the determined rate of change of the weight of the urine collection chamber and the set desired fluid balance, and control the infusion pump to hydrate the patient based at least on the calculated desired infusion rate.
- This invention also features a fluid management system including a console which includes an input for setting a desired fluid balance, a urine collection chamber, a weighing device for weighing the patient's urine output collected in the urine collection chamber, a source of hydration fluid, a pump associated with the console and configured to pump hydration fluid form the source of hydration fluid into the patient, and a controller in the console configured to: determine the patient's urine output based on the weight of the urine collection chamber, operate the pump, monitor the amount of hydration fluid injected into the patient based, and control the pump based on the set desired fluid balance, the amount of hydration fluid injected into the patient, and the determined patient urine output.
- a console which includes an input for setting a desired fluid balance, a urine collection chamber, a weighing device for weighing the patient's urine output collected in the urine collection chamber, a source of hydration fluid, a pump associated with the console and configured to pump hydration fluid form the source of hydration fluid into the patient, and a controller in
- This invention also features a fluid management system for a patient including a console for mounting on an IV pole.
- the console includes an input for setting a desired fluid balance, a first attachment mechanism extends from the console for handing a urine collection chamber.
- a weighing device in the console is responsive to the first attachment mechanism for weighing the patient's urine output collected in the urine collection chamber.
- a controllable infusion pump is integrated with the console and configured to pump hydration fluid from a source of hydration fluid into the patient at a variable rate.
- a controller in the console is responsive to the set desired fluid balance and the weighing device.
- the controller is configured to determine the patient's urine output based on the rate of change of the weight of the urine collection chamber, calculate a desired infusion rate based on the determined rate of change of the weight of the urine collection chamber and the set desired fluid balance, and control the infusion pump to hydrate the patient based at least on the calculated desired infusion rate.
- This invention further features a method of addressing contrast induced nephropathy.
- One method includes injecting a contrast agent into a patient, imaging the patient, and including diuresis to drive any contrast agent through the patient's kidneys to reduce its toxic effects on the kidneys and prevent damage to the kidneys.
- a desired fluid balance is set.
- Urine expelled by the patient is collected in a urine collection bag.
- the method typically includes weighing the urine collection bag, employing a pump to infuse the patient with fluid from a fluid source, weighing the fluid source, and automatically adjusting the pump based on the weight of the urine collection bag and the weight of the fluid source and controlling the amount of fluid infused into the patient based on the amount of urine expelled by the patient and the set desired fluid balance.
- the method may include the step of administering a diuretic to the patient.
- Collecting urine expelled by the patient may include catheterizing the patient.
- Catheterizing the patient may include inserting a urinary catheter in the urinary tract of the patient.
- Weighing the urine collection bag may include providing an indication when a urine collection bag has reached its capacity.
- the method may further include providing an indication when the fluid source is low on fluid.
- This invention also features a method of addressing contrast induced nephropathy for a patient who has had a contrast agent injected into the patient.
- the method includes collecting urine expelled by the patient, determining the amount of urine expelled by the patient based on the collected urine, infusing the patient with fluid from a fluid source, determining the amount of fluid infused into the patient, and inducing dieresis to dilute the concentration of any contrast agent in the patient by automatically adjusting the amount of fluid infused into the patient from the fluid source based on the determined amount of urine expelled by the patient to balance the amount of urine expelled by the patient with the amount of fluid infused into the patient.
- This invention also features a method of driving a toxin through a patient's kidneys, the method including collecting urine expelled by the patient.
- the method includes determining the amount of urine expelled by the patient based on the collected urine, infusing the patient with fluid from a fluid source, determining the amount of fluid infused into the patient, and inducing diuresis by automatically adjusting the amount of fluid infused into the patient from the fluid source on the determined amount of urine expelled by the patient to balance the amount of urine expelled by the patient with the amount of fluid infused into the patient.
- This invention also features a method of preventing kidney damage due to dehydration, the method including collecting urine expelled by the patient.
- the method includes determining the amount of urine expelled by the patient based on the collected urine, infusing the patient with fluid from a fluid source, determining the amount of fluid infused into the patient, and maintaining the patient's hydration level by automatically adjusting the amount of fluid infused into the patient from the fluid source based on the determined amount of urine expelled by the patient to balance the amount of urine expelled by the patient with the amount of fluid infused into the patient, increasing the patient's level of hydration by infusing additional fluid based on user settings over and above fluid infused to match the patient's urine output.
- FIG. 1 is a schematic view of an example of a patient hydration system in accordance with the subject invention
- FIG. 2 is a schematic view of one embodiment of a patient hydration system in accordance with the subject invention wherein the weight of the urine output by a patient is measured and used as an input to control the infusion rate of an infusion pump;
- FIG. 3 is a schematic view of another embodiment of a patient hydration system in accordance with the subject invention wherein the controller and weighing mechanism are integrated in a single control subsystem unit;
- FIG. 4 is a flow chart depicting one example of the software associated with the controller of this invention and the method of adjusting the infusion rate based on the amount of urine output by the patient;
- FIG. 5 is a schematic view showing another embodiment of the subject invention wherein a flow meter is used to determine the amount of urine output by the patient.
- Patient hydration system 10 FIG. 1 according to this invention includes urine collection system 12 connected to patient P.
- Infusion system 20 typically includes an infusion device such as infusion pump 22 (e.g., a peristaltic pump) connected to source 24 of infusion fluid 26 (e.g., saline) by tubing 28 .
- I.V. needle 30 is inserted in a vein of patient P and is connected to infusion pump 22 via tubing 32 .
- a control system or hydration balance means 34 detects the amount of urine output by the patient and automatically adjusts the infusion rate of infusion pump 22 to achieve, as necessary, a zero, positive, or negative net fluid balance in the patient.
- urine collection system 12 includes catheter 14 (e.g., a Foley catheter) placed in the bladder B of patient P.
- Tubing 16 connects catheter 14 to meter 36 .
- Controller 38 typically programmable, is responsive to the output of meter 36 and is configured to adjust the infusion rate of infusion pump 22 .
- meter 36 , FIG. 1 is a weight measurement device such as scale 50 , FIG. 2 .
- urine collection chamber 52 on scale 50 is connected to catheter 14 via tubing 16 .
- Scale 50 outputs a signal corresponding to the weight of urine or the combined weight of urine and hydration fluid (in this case to maintain net-zero hydration, the scale reading should be maintained constant) or the difference between the weight of urine and the weight of hydration fluid in collection chamber 52 to controller 38 .
- the patient hydration system of this invention may further include diuretic administration system 60 including a source 62 of a diuretic such as furosemide administered via I.V. 64 inserted in patient P and connected to source 62 via tubing 66 .
- tubing 66 can be connected to the patient P via hydration I.V. 30 using standard clinical techniques.
- a urine pump such as, for example, peristaltic pump 70 can be used to urge urine from bladder B to collection chamber 52 and to automatically flush catheter 14 if it is occluded.
- the advantage of urine collection pump 70 is that collection chamber or bag 52 can be at any height relative to the patient P.
- chamber 24 containing the hydration fluid 26 can also be placed on scale 50 in an embodiment where differential weighing is used.
- the controller ( 38 ) electronics and software are capable of integrating urine output (for example every 15 or 30 minutes) and changing the infusion rate setting of the infusion pump 22 following an algorithm executed by the controller.
- Electronic controller 22 may also incorporate a more advanced feature allowing the physician to set a desired (for example positive) hydration net goal. For example, the physician may set the controller to achieve positive net gain of 400 ml in 4 hours. Controller 38 calculates the trajectory and adjust the infusion pump flow rate setting to exceed the urine output accordingly. For example, to achieve a positive net gain of 400 ml over 4 hour, controller 38 may infuse additional 25 ml of hydration fluid every 15 minutes in addition to the volume of urine made by the patient in each 15 minute interval.
- the programmable controller and the weighing mechanism are integrated in controller unit 34 ′′.
- the patient See FIG. 1
- the hydration I.V. 30 and the urinary collection (Foley) catheter 14 are inserted using standard methods.
- the controller electronics and the infusion pump 22 ′ are integrated in the single enclosure of the control subsystem 34 ′′ console 82 .
- Console 82 is mounted on I.V. pole 84 .
- Control subsystem 34 ′′ may also include electronic air detector 86 that prevents infusion of air into the patient.
- the air detector 86 is of ultrasonic type and can detect air in amounts exceeding approximately 50 micro liters traveling inside the infusion tubing 32 .
- air detector 86 employs technology based on the difference of the speed of sound in liquid and in gaseous media. If an air bubble is detected, the pump 22 ′ is stopped almost instantaneously.
- Console 82 may include one or more weight scales such as an electronic strain gage and other means to periodically detect the weight of the collected urine in chamber 52 and, if desired, the weight of the remaining hydration fluid in chamber 26 .
- bag 52 with collected urine and the bag 24 with hydration fluid 26 are hanging off the hooks 90 and 92 connected to the balance.
- the bags with fluids are suspended from the hooks and a system of levers translate force to a scale such as strain gage 22 ′.
- the strain gage converts force into an electronic signal that can be read controller 34 ′′.
- Suitable electronic devices for accurately measuring weight of a suspended bag with urine are available from Strain Measurement Devices, 130 Research Parkway, Meriden, Conn., 06450.
- These devices include electronics and mechanical components necessary to accurately measure and monitor weight of containers with medical fluids such as one or two-liter plastic bags of collected urine.
- medical fluids such as one or two-liter plastic bags of collected urine.
- the overload proof single point load cell model S300 and the model S215 load cell from Strain Measurement Devices are particularly suited for scales, weighing bottles or bags in medical instrumentation applications. Options and various specifications and mounting configurations of these devices are available.
- These low profile single point sensors are intended for limited space applications requiring accurate measurement of full-scale forces of 2, 4, and 12 pounds-force. They can be used with a rigidly mounted platform or to measure tensile or compressive forces.
- a 10,000 ⁇ wheatstone bridge offers low power consumption for extended battery life in portable products.
- the purpose of the weight measurement is to detect the increasing weight of the collected urine in the bag 52 and to adjust the rate of infusion or hydration based on the rate of urine flow.
- Console 82 is also typically equipped with the user interface.
- the interface allows the user to set (dial in) the two main parameters of therapy: the duration of hydration and the desired net fluid balance at the end.
- the net fluid balance can be zero if no fluid gain or loss is desired.
- Display indicators on the console show the current status of therapy: the elapsed time 100 and the net fluid gain or loss 102 .
- the user interface may also include alarms 104 .
- the alarms notify the user of therapy events such as an empty fluid bag or a full collection bag as detected by the weight scale.
- the urine is collected by gravity. If urine collection unexpectedly stops for any reason, the system will reduce and, if necessary, stop the IV infusion of fluid and alarm the user.
- the console can include the second (urine) pump (see pump 70 , FIG. 2 ) similar to infusion pump 22 . This configuration has an advantage of not depending on the bag height for drainage and the capability to automatically flush the catheter 14 , FIG. 3 if it is occluded by temporarily reversing the pump flow direction.
- FIG. 4 illustrates an algorithm that can be used by the controller software of controller 34 ′′ to execute the desired therapy.
- the algorithm is executed periodically based on a controller internal timer clock. It is appreciated that the algorithm can be made more complex to improve the performance and safety of the device.
- Controller 34 ′′, FIG. 3 is programmed to determine the rate of change of the urine weight, steps 110 and 112 , FIG. 4 to calculate a desired infusion rate based on the rate of change of the urine weight, step 114 , and to adjust the infusion rate of the infusion pump 22 , FIG. 3 based on the calculated desired infusion rate, step 116 , FIG. 4 .
- the subject invention has been described in connection with the best mode now known to the applicant.
- the subject invention is not to be limited to these disclosed embodiments. Rather, the invention covers all of various modifications and equivalent arrangements included within the spirit and scope of the appended claims.
- the embodiments used to illustrate the invention use the weight of the collected urine for balancing. It is understood that it is the volume of the urine that is clinically important but the weight of the urine is equivalent for any practical purpose. For the purpose of this application, 100 grams of urine are the same as 100 ml of urine. It is believed at the time of the subject invention that measuring weight is more practical than measuring volume and that the weight is often used as a clinically acceptable substitute of volume of liquids that consist mostly of water.
- the specific gravity (specific gravity of a substance is a comparison of its density to that of water) of urine and hydration fluids is the same as water.
- a meter which monitors the height of the column of the liquid in a vessel or by integrating the known volume of strokes of the pump over time. The exact meter used does not change the subject invention in regard to the balancing of urine output with hydration.
- flow meter 36 ′, FIG. 5 could be used to measure the urine output of patient P and a signal corresponding to the flow rate provided to controller 38 .
- Urine flow meter 36 ′, FIG. 5 can be one of the devices disclosed in U.S. Pat. Nos. 5,891,051; 5,176,148; 4,504,263; and 4,343,316 hereby incorporated herein by this reference.
- the UREXACT 2000 System is an accurate electronic urine-measuring device that combines an innovative disposable collection unit with a re-usable automatic electronic meter to provide precise urine monitoring.
- the UREXACT 2000 is based on the ultrasonic method of measuring fluid flow.
Abstract
A fluid management system for a patient includes a console for mounting on an IV pole. The console includes an input for setting a desired fluid balance for a set therapy duration. A weighing subsystem weighs the patient's urine output collected in a urine collection chamber and weighs a source of hydration fluid. An infusion pump is integrated with the console and is configured to pump hydration fluid from the source of hydration fluid into the patient. A controller in the console is responsive to the set desired fluid balance, the set therapy duration, and the weighing subsystem. The controller is configured to determine the patient's urine output based on the weight of the urine collection chamber, determine the amount of fluid infused into the patient, and control the infusion pump to inject hydration fluid into the patient based on the set desired fluid balance, the weight of the urine collection chamber, and the weight of the source of hydration fluid to achieve the desired fluid balance during the set therapy duration.
Description
- This application is a divisional of prior U.S. patent application Ser. No. 10/936,945 filed Sep. 9, 2004, which is incorporated herein by reference.
- This invention relates to a patient hydration system and method wherein the rate of hydration fluid delivered to the patient is automatically adjusted based on the urine output of the patient to maintain, as necessary, a zero, positive, or negative net fluid balance in the patient.
- There are many medical procedures in which proper hydration of the patient is critical. For example, it has been observed that dehydration increases the risk of radiocontrast nephropathy (RCN) when radiocontrast agents are injected into a patient during coronary and peripheral vascular catheterization procedures. RCN is the third most common cause of hospital-acquired renal failure. It occurs in over 5% of patients with any baseline renal insufficiency and in 50% of patients with preexisting chronic renal insufficiency and diabetes. Radiocontrast media has a variety of physiologic effects believed to contribute to the development of RCN. One of the main contributors is renal medullary ischemia, which results from a severe, radiocontrast-induced reduction in renal/intrarenal blood flow and oxygen delivery. The medullary ischemia induces ischemia and/or death of the metabolically active areas of the medulla responsible for urine formation, called the renal tubules. Medullary ischemia is attributed to the increase of oxygen demand by the kidney struggling to remove the radiocontrast media from blood plasma and excrete it from the body at the same time as the normal process of controlling the concentration of urine. Oxygen consumption in the medulla of the kidney is directly related to the work of concentrating urine. Since the presence of radiocontrast media in the urine makes it much more difficult for the kidney to concentrate urine, the work of the medulla outstrips the available oxygen supply and leads to medullary ischemia.
- Although the exact mechanisms of RCN remain unknown, it has been consistently observed that patients with high urine output are less vulnerable to contrast injury. It is also clear that dehydration increases the risk of RCN, likely because urine (and contrast media inside the kidney) is excessively concentrated. As a result, patients predisposed to RCN are hydrated via intravenous infusion of normal saline before, during and after the angiographic procedure. Hydration is commonly performed at a conservative rate, especially in patients with existing heart and kidney dysfunction, since over-hydration can result in pulmonary edema (fluid in the lungs), shortness of breath, the need for intubation, and even death. Thus, the patients at highest risk for RCN are those least likely to receive the only proven therapy for preventing RCN (I.V. hydration) due to the unpredictability of side effects from I.V. hydration.
- A major limitation to the more widespread use of the already known therapeutic, or optimal, levels of I.V. hydration is the current inability to balance the amount of fluid going into the patient to the amount of fluid being removed or excreted from the patient. It is possible to have a nurse measure a patient's urine output frequently but this method is impractical as nurses are often responsible for the care of many patients. In addition, the only accurate method of measuring urine output is to place a catheter into the patient's urinary bladder. Without a catheter, the patient must excrete the urine that may have been stored in the bladder for several hours. During this time, the amount of I.V. hydration can be significantly less than the amount of urine produced by the kidneys and stored in the bladder, leading to dehydration. Since patients do not normally have such a catheter during procedures using radiocontrast media, a valid measurement of urine output is not possible.
- There seems to be indisputable scientific evidence that RCN in patients with even mild baseline renal insufficiency can lead to long term complications and even increased risk of mortality. This scientific knowledge has not yet been extended to daily clinical practice as routine monitoring of renal function post-catheterization is not performed and limits the identification of the known short-term clinical complications.
- At the same time, there is a great deal of awareness in clinical practice that patients with serious renal insufficiency (serum creatinine (Cr)≧2.0) often suffer serious and immediate damage from contrast. Many cardiologists go considerable length to protect these patients including slow, overnight hydration (an extra admission day), administration of marginally effective but expensive drugs, or even not performing procedures at all.
- There are approximately 1 million inpatient and 2 million outpatient angiography and angioplasty procedures performed in the U.S. per year (based on 2001 data). Based on the largest and most representative published studies of RCN available to us (such as Mayo Clinic PCI registry of 7,586 patients) we believe that 4% of patients have serious renal insufficiency (Cr≧2.0). This results in the initial market potential of 40 to 120 thousand cases per year from interventional cardiology alone. There is also a significant potential contribution from peripheral vascular procedures, CT scans and biventricular pacemaker leads placement. As the awareness of the RCN increases, the market can be expected to increase to 10% or more of all cases involving contrast.
- According to the prior art, hydration therapy is given intravenously (I.V.) when someone is losing necessary fluids at a rate faster than they are retaining fluids. By giving the hydration therapy with an I.V., the patient receives the necessary fluids much faster than by drinking them. Also, dehydration can be heightened by hyperemesis (vomiting), therefore the I.V. method eliminates the need to take fluids orally. An anesthetized or sedated patient may not be able to drink. Hydration is used in clinical environments such as surgery, ICU, cathlab, oncology center and many others. At this time, hydration therapy is performed using inflatable pressure bags and/or I.V. pumps. A number of I.V. pumps on the market are designed for rapid infusion of fluids (as opposed to slow I.V. drug delivery) for perioperative hydration during surgery, ICU use and even emergency use for fluid resuscitation.
- An infusion pump is a device used in a health care facility to pump fluids into a patient in a controlled manner. The device may use a piston pump, a roller pump, or a peristaltic pump and may be powered electrically or mechanically. The device may also operate using a constant force to propel the fluid through a narrow tube, which determines the flow rate. The device may include means to detect a fault condition, such as air in, or blockage of, the infusion line and to activate an alarm.
- An example of a device for rapid infusion of fluids is the Infusion Dynamics (Plymouth Meeting, Pa.) Power Infuser. The Power Infuser uses two alternating syringes as a pumping engine. Since it is only intended to deliver fluids (not medication), the Power Infuser has accuracy of 15%. It provides a convenient way to deliver colloid as well as crystalloid for hydration during the perioperative period among other possible clinical settings. The Power Infuser provides anesthesiologists with the ability to infuse at rates similar to that seen with pressure bags, but with more exact volume control. The maximum infusion rate is 6 L/hr. It has the flexibility of infusing fluid at 0.2, 1, 2, 4 and 6 L/hr. A bolus setting of 250 mL will deliver that volume in 2.5 min. In a large blood loss surgical case, the use of Power Infuser enables large volumes of colloid to be delivered to restore hemodynamics.
- It is also known in the art that loop diuretics such as furosemide (frusemide) reduce sodium reabsorption and consequentially reduce oxygen consumption of the kidney. They also reduce concentration of contrast agents in the urine-collecting cavities of the kidney. They induce diuresis (e.g., patient produces large quantities of very dilute urine) and help remove contrast out of the kidney faster. Theoretically, they should be the first line of defense against RCN. In fact, they were used to prevent RCN based on this assumption until clinical evidence suggested that they were actually deleterious. More recently, doubts have been raised regarding the validity of those negative clinical studies.
- In two clinical studies by Solomon R., Werner C, Mann D. et al. “Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents”, N Engl J Med, 1994; 331:1416-1420 and by Weinstein J. M., Heyman S., Brezis M. “Potential deleterious effect of furosemide in radiocontrast nephropathy”, Nephron 1992; 62:413-415, as compared with hydration protocol, hydration supplemented with furosemide adversely affected kidney function in high-risk patients given contrast. Weinstein et al. found that furosemide-treated subjects lost 0.7 kg on average, whereas a 1.3-kg weight gain was noted in patients randomized to hydration alone, suggesting that in furosemide-treated subjects the hydration protocol has been insufficient and patients were dehydrated by excessive diuresis.
- The clinical problem is simple to understand: diuresis is widely variable and unpredictable but the fluid replacement (hydration) at a constant infusion rate is prescribed in advance. To avoid the risk of pulmonary edema, fluid is typically given conservatively at 1 ml/hr per kg of body weight. The actual effect of diuretic is typically not known for 4 hours (until the sufficient amount of urine is collected and measured) and it is too late and too difficult to correct any imbalance. Meanwhile, patients could be losing fluid at 500 ml/hour while receiving the replacement at only 70 ml/hour. The effects of forced diuresis without balancing are illustrated in the research paper by Wakelkamp et. al. “The Influence of Drug input rate on the development of tolerance to furosemide” Br J. Clin. Pharmacol. 1998; 46: 479-487. In that study, diuresis and natriuresis curves were generated by infusing 10 mg of I.V. furosemide over 10 min to human volunteers. From that paper it can be seen that a patient can lose 1,300 ml of urine within 8 hours following the administration of this potent diuretic. Standard unbalanced I.V. hydration at 75 ml/h will only replace 600 ml in 8 hours. As a result the patient can lose “net” 700 ml of body fluid and become dehydrated. If such patient is vulnerable to renal insult, they can suffer kidney damage.
- To illustrate the concept further, the effects of diuretic therapy on RCN were recently again investigated in the PRINCE study by Stevens et al. in “A Prospective Randomized Trial of Prevention Measures in Patients at High Risk for Contrast Nephropathy, Results of the PRINCE. Study” JACC Vol. 33, No. 2, 1999 February 1999:403-11. This study demonstrated that the induction of a forced diuresis while attempting to hold the intravascular volume in a constant state with replacement of urinary losses provided a modest protective benefit against contrast-induced renal injury, and importantly, independent of baseline renal function. This is particularly true if mean urine flow rates were above 150 ml/h. Forced diuresis was induced with intravenous crystalloid, furosemide, and mannitol beginning at the start of angiography.
- The PRINCE study showed that, in contrast to the Weinstein study, forced diuresis could be beneficial to RCN patients if the intravascular volume was held in a constant state (no dehydration). Unfortunately, there are currently no practical ways of achieving this in a clinical setting since in response to the diuretic infusion the patient's urine output changes rapidly and unpredictably. In the absence of special equipment, it requires a nurse to calculate urine output every 15-30 minutes and re-adjust the I.V. infusion rate accordingly. While this can be achieved in experimental setting, this method is not possible in current clinical practice where nursing time is very limited and one nurse is often responsible for monitoring the care of up to ten patients. In addition, frequent adjustments and measurements of this kind often result in a human error.
- Forced hydration and forced diuresis are known art that has been practiced for a long time using a variety of drugs and equipment. There is a clear clinical need for new methods and devices that will make this therapy accurate, simple to use and safe.
- It is therefore an object of this invention to provide a patient hydration system and method.
- It is a further object of this invention to provide such a system and method which prevents kidney damage in a patient.
- It is a further object of this invention to provide such a system and method which protects the patient undergoing a medical procedure involving a radiocontrast agent from kidney damage.
- It is a further object of this invention to provide such a system and method which incorporates a balancing feature intended to prevent dehydration, overhydration, and to maintain a proper intravascular volume.
- It is a further object of this invention to provide a balanced diuresis method which automatically balances fluid loss in the urine.
- It is a further object of this invention to provide such a system and method which is accurate, easy to implement, and simple to operate.
- It is a further object of this invention to provide such a system and method which is particularly useful in the clinical setting of forced diuresis with drugs known as I.V. loop diuretics.
- The invention results from the realization that radiocontrast nephropathy in particular and patient dehydration in general can be prevented by automatically measuring the urine output of the patient and adjusting the rate of delivery of a hydration fluid to the patient to achieve, as necessary, a zero, positive, or negative net fluid balance in the patient.
- This invention features, in one aspect, a fluid management system for a patient. The system typically includes a console for mounting on an IV pole. The console includes an input for setting a desired fluid balance for a set therapy duration. A first attachment mechanism extends from the console for hanging a urine collection chamber. A second attachment mechanism extends from the console for hanging a source of hydration fluid. A weighing subsystem in the console is responsive to the first attachment mechanism for weighing the patient's urine output collected in the urine collection chamber and is responsive to the second attachment mechanism for weighing the source of hydration fluid. An infusion pump is integrated with the console and configured to pump hydration fluid from the source of hydration fluid into the patient. A controller in the console is responsive to the set desired fluid balance, the set therapy duration, and the weighing subsystem. The controller is configured to determine the patient's urine output based on the weight of the urine collection chamber, determine the amount of fluid infused into the patient, and control the infusion pump to inject hydration fluid into the patient based on the set desired fluid balance, the weight of the urine collection chamber, and the weight of the source of hydration fluid to achieve the desired fluid balance during the set therapy duration.
- In one embodiment, the console may include a display which displays the elapsed time of the therapy duration and the current fluid balance. The system may include means for indicating, on the console, when the urine collection is empty. The system may include means for indicating, on the console, when the source of hydration fluid is low on fluid. The controller may be configured to determine the patient's urine output based on the rate of change of the weight of the urine collection chamber, calculate a desired infusion rate based on the determined rate of change of the weight of the urine collection chamber and the set desired fluid balance, and control the infusion pump to hydrate the patient based at least on the calculated desired infusion rate.
- This invention also features a fluid management system including a console which includes an input for setting a desired fluid balance, a urine collection chamber, a weighing device for weighing the patient's urine output collected in the urine collection chamber, a source of hydration fluid, a pump associated with the console and configured to pump hydration fluid form the source of hydration fluid into the patient, and a controller in the console configured to: determine the patient's urine output based on the weight of the urine collection chamber, operate the pump, monitor the amount of hydration fluid injected into the patient based, and control the pump based on the set desired fluid balance, the amount of hydration fluid injected into the patient, and the determined patient urine output.
- This invention also features a fluid management system for a patient including a console for mounting on an IV pole. The console includes an input for setting a desired fluid balance, a first attachment mechanism extends from the console for handing a urine collection chamber. A weighing device in the console is responsive to the first attachment mechanism for weighing the patient's urine output collected in the urine collection chamber. A controllable infusion pump is integrated with the console and configured to pump hydration fluid from a source of hydration fluid into the patient at a variable rate. A controller in the console is responsive to the set desired fluid balance and the weighing device. The controller is configured to determine the patient's urine output based on the rate of change of the weight of the urine collection chamber, calculate a desired infusion rate based on the determined rate of change of the weight of the urine collection chamber and the set desired fluid balance, and control the infusion pump to hydrate the patient based at least on the calculated desired infusion rate.
- This invention further features a method of addressing contrast induced nephropathy. One method includes injecting a contrast agent into a patient, imaging the patient, and including diuresis to drive any contrast agent through the patient's kidneys to reduce its toxic effects on the kidneys and prevent damage to the kidneys. A desired fluid balance is set. Urine expelled by the patient is collected in a urine collection bag. The method typically includes weighing the urine collection bag, employing a pump to infuse the patient with fluid from a fluid source, weighing the fluid source, and automatically adjusting the pump based on the weight of the urine collection bag and the weight of the fluid source and controlling the amount of fluid infused into the patient based on the amount of urine expelled by the patient and the set desired fluid balance.
- In another embodiment, the method may include the step of administering a diuretic to the patient. Collecting urine expelled by the patient may include catheterizing the patient. Catheterizing the patient may include inserting a urinary catheter in the urinary tract of the patient. Weighing the urine collection bag may include providing an indication when a urine collection bag has reached its capacity. The method may further include providing an indication when the fluid source is low on fluid.
- The subject invention, however, in other embodiments, need not achieve all these objectives and the claims hereof should not be limited to structures or methods capable of achieving these objectives.
- This invention also features a method of addressing contrast induced nephropathy for a patient who has had a contrast agent injected into the patient. The method includes collecting urine expelled by the patient, determining the amount of urine expelled by the patient based on the collected urine, infusing the patient with fluid from a fluid source, determining the amount of fluid infused into the patient, and inducing dieresis to dilute the concentration of any contrast agent in the patient by automatically adjusting the amount of fluid infused into the patient from the fluid source based on the determined amount of urine expelled by the patient to balance the amount of urine expelled by the patient with the amount of fluid infused into the patient.
- This invention also features a method of driving a toxin through a patient's kidneys, the method including collecting urine expelled by the patient. The method includes determining the amount of urine expelled by the patient based on the collected urine, infusing the patient with fluid from a fluid source, determining the amount of fluid infused into the patient, and inducing diuresis by automatically adjusting the amount of fluid infused into the patient from the fluid source on the determined amount of urine expelled by the patient to balance the amount of urine expelled by the patient with the amount of fluid infused into the patient.
- This invention also features a method of preventing kidney damage due to dehydration, the method including collecting urine expelled by the patient. The method includes determining the amount of urine expelled by the patient based on the collected urine, infusing the patient with fluid from a fluid source, determining the amount of fluid infused into the patient, and maintaining the patient's hydration level by automatically adjusting the amount of fluid infused into the patient from the fluid source based on the determined amount of urine expelled by the patient to balance the amount of urine expelled by the patient with the amount of fluid infused into the patient, increasing the patient's level of hydration by infusing additional fluid based on user settings over and above fluid infused to match the patient's urine output.
- Other objects, features and advantages will occur to those skilled in the art from the following description of a preferred embodiment and the accompanying drawings, in which:
-
FIG. 1 is a schematic view of an example of a patient hydration system in accordance with the subject invention; -
FIG. 2 is a schematic view of one embodiment of a patient hydration system in accordance with the subject invention wherein the weight of the urine output by a patient is measured and used as an input to control the infusion rate of an infusion pump; -
FIG. 3 is a schematic view of another embodiment of a patient hydration system in accordance with the subject invention wherein the controller and weighing mechanism are integrated in a single control subsystem unit; -
FIG. 4 is a flow chart depicting one example of the software associated with the controller of this invention and the method of adjusting the infusion rate based on the amount of urine output by the patient; and -
FIG. 5 is a schematic view showing another embodiment of the subject invention wherein a flow meter is used to determine the amount of urine output by the patient. - Aside from the preferred embodiment or embodiments disclosed below, this invention is capable of other embodiments and of being practiced or being carried out in various ways. Thus, it is to be understood that the invention is not limited in its application to the details of construction and the arrangements of components set forth in the following description or illustrated in the drawings. If only one embodiment is described herein, the claims hereof are not to be limited to that embodiment. Moreover, the claims hereof are not to be read restrictively unless there is clear and convincing evidence manifesting a certain exclusion, restriction, or disclaimer.
-
Patient hydration system 10,FIG. 1 according to this invention includesurine collection system 12 connected to patientP. Infusion system 20 typically includes an infusion device such as infusion pump 22 (e.g., a peristaltic pump) connected to source 24 of infusion fluid 26 (e.g., saline) bytubing 28. I.V.needle 30 is inserted in a vein of patient P and is connected to infusion pump 22 viatubing 32. - A control system or hydration balance means 34 detects the amount of urine output by the patient and automatically adjusts the infusion rate of infusion pump 22 to achieve, as necessary, a zero, positive, or negative net fluid balance in the patient. Typically,
urine collection system 12 includes catheter 14 (e.g., a Foley catheter) placed in the bladder B ofpatient P. Tubing 16 connectscatheter 14 tometer 36.Controller 38, typically programmable, is responsive to the output ofmeter 36 and is configured to adjust the infusion rate ofinfusion pump 22. - In one example,
meter 36,FIG. 1 is a weight measurement device such asscale 50,FIG. 2 . Here,urine collection chamber 52 onscale 50 is connected tocatheter 14 viatubing 16.Scale 50 outputs a signal corresponding to the weight of urine or the combined weight of urine and hydration fluid (in this case to maintain net-zero hydration, the scale reading should be maintained constant) or the difference between the weight of urine and the weight of hydration fluid incollection chamber 52 tocontroller 38. The patient hydration system of this invention may further includediuretic administration system 60 including asource 62 of a diuretic such as furosemide administered via I.V. 64 inserted in patient P and connected to source 62 viatubing 66. In alternative embodiment,tubing 66 can be connected to the patient P via hydration I.V. 30 using standard clinical techniques. Also, if desired, a urine pump such as, for example,peristaltic pump 70 can be used to urge urine from bladder B tocollection chamber 52 and to automaticallyflush catheter 14 if it is occluded. The advantage ofurine collection pump 70 is that collection chamber orbag 52 can be at any height relative to the patient P. As shown,chamber 24 containing thehydration fluid 26 can also be placed onscale 50 in an embodiment where differential weighing is used. The controller (38) electronics and software are capable of integrating urine output (for example every 15 or 30 minutes) and changing the infusion rate setting of theinfusion pump 22 following an algorithm executed by the controller. -
Electronic controller 22 may also incorporate a more advanced feature allowing the physician to set a desired (for example positive) hydration net goal. For example, the physician may set the controller to achieve positive net gain of 400 ml in 4 hours.Controller 38 calculates the trajectory and adjust the infusion pump flow rate setting to exceed the urine output accordingly. For example, to achieve a positive net gain of 400 ml over 4 hour,controller 38 may infuse additional 25 ml of hydration fluid every 15 minutes in addition to the volume of urine made by the patient in each 15 minute interval. - In the embodiment of
FIG. 3 , the programmable controller and the weighing mechanism are integrated incontroller unit 34″. The patient (SeeFIG. 1 ) is placed on the hospital bed or operating table 80. The hydration I.V. 30 and the urinary collection (Foley)catheter 14 are inserted using standard methods. The controller electronics and theinfusion pump 22′ are integrated in the single enclosure of thecontrol subsystem 34″console 82.Console 82 is mounted on I.V.pole 84. -
Control subsystem 34″ may also includeelectronic air detector 86 that prevents infusion of air into the patient. Theair detector 86 is of ultrasonic type and can detect air in amounts exceeding approximately 50 micro liters traveling inside theinfusion tubing 32. In one example,air detector 86 employs technology based on the difference of the speed of sound in liquid and in gaseous media. If an air bubble is detected, thepump 22′ is stopped almost instantaneously. -
Console 82 may include one or more weight scales such as an electronic strain gage and other means to periodically detect the weight of the collected urine inchamber 52 and, if desired, the weight of the remaining hydration fluid inchamber 26. In the proposed embodiment,bag 52 with collected urine and thebag 24 withhydration fluid 26 are hanging off thehooks strain gage 22′. The strain gage converts force into an electronic signal that can be readcontroller 34″. Suitable electronic devices for accurately measuring weight of a suspended bag with urine are available from Strain Measurement Devices, 130 Research Parkway, Meriden, Conn., 06450. These devices include electronics and mechanical components necessary to accurately measure and monitor weight of containers with medical fluids such as one or two-liter plastic bags of collected urine. For example, the overload proof single point load cell model S300 and the model S215 load cell from Strain Measurement Devices are particularly suited for scales, weighing bottles or bags in medical instrumentation applications. Options and various specifications and mounting configurations of these devices are available. These low profile single point sensors are intended for limited space applications requiring accurate measurement of full-scale forces of 2, 4, and 12 pounds-force. They can be used with a rigidly mounted platform or to measure tensile or compressive forces. A 10,000 Å wheatstone bridge offers low power consumption for extended battery life in portable products. Other examples of gravimetric scales used to balance medical fluids using a controller controlling the rates of fluid flow from the pumps in response to the weight information can be found in U.S. Pat. Nos. 5,910,252; 4,132,644; 4,204,957; 4,923,598; and 4,728,433 incorporated herein by this reference. - It is understood that there are many known ways in the art of engineering to measure weight and convert it into computer inputs. Regardless of the implementation, the purpose of the weight measurement is to detect the increasing weight of the collected urine in the
bag 52 and to adjust the rate of infusion or hydration based on the rate of urine flow. -
Console 82 is also typically equipped with the user interface. The interface allows the user to set (dial in) the two main parameters of therapy: the duration of hydration and the desired net fluid balance at the end. The net fluid balance can be zero if no fluid gain or loss is desired. Display indicators on the console show the current status of therapy: the elapsedtime 100 and the net fluid gain orloss 102. - The user interface may also include
alarms 104. The alarms notify the user of therapy events such as an empty fluid bag or a full collection bag as detected by the weight scale. In one proposed embodiment, the urine is collected by gravity. If urine collection unexpectedly stops for any reason, the system will reduce and, if necessary, stop the IV infusion of fluid and alarm the user. Alternatively, the console can include the second (urine) pump (seepump 70,FIG. 2 ) similar toinfusion pump 22. This configuration has an advantage of not depending on the bag height for drainage and the capability to automatically flush thecatheter 14,FIG. 3 if it is occluded by temporarily reversing the pump flow direction. -
FIG. 4 illustrates an algorithm that can be used by the controller software ofcontroller 34″ to execute the desired therapy. The algorithm is executed periodically based on a controller internal timer clock. It is appreciated that the algorithm can be made more complex to improve the performance and safety of the device.Controller 34″,FIG. 3 is programmed to determine the rate of change of the urine weight, steps 110 and 112,FIG. 4 to calculate a desired infusion rate based on the rate of change of the urine weight,step 114, and to adjust the infusion rate of theinfusion pump 22,FIG. 3 based on the calculated desired infusion rate,step 116,FIG. 4 . - So far, the subject invention has been described in connection with the best mode now known to the applicant. The subject invention, however, is not to be limited to these disclosed embodiments. Rather, the invention covers all of various modifications and equivalent arrangements included within the spirit and scope of the appended claims. Particularly, the embodiments used to illustrate the invention use the weight of the collected urine for balancing. It is understood that it is the volume of the urine that is clinically important but the weight of the urine is equivalent for any practical purpose. For the purpose of this application, 100 grams of urine are the same as 100 ml of urine. It is believed at the time of the subject invention that measuring weight is more practical than measuring volume and that the weight is often used as a clinically acceptable substitute of volume of liquids that consist mostly of water. For practical purposes, the specific gravity (specific gravity of a substance is a comparison of its density to that of water) of urine and hydration fluids is the same as water. Those skilled in the art will realize that it is possible to measure volume directly using a meter which monitors the height of the column of the liquid in a vessel or by integrating the known volume of strokes of the pump over time. The exact meter used does not change the subject invention in regard to the balancing of urine output with hydration. Also, flow
meter 36′,FIG. 5 could be used to measure the urine output of patient P and a signal corresponding to the flow rate provided tocontroller 38.Urine flow meter 36′,FIG. 5 can be one of the devices disclosed in U.S. Pat. Nos. 5,891,051; 5,176,148; 4,504,263; and 4,343,316 hereby incorporated herein by this reference. - Also a medical device manufacturer, SFM Ltd., 14 Oholiav Street, Jerusalem, 94467, Israel manufactures and markets an electronic flow meter suitable for use with this invention. According to the manufacturer SFM Ltd. the UREXACT 2000 System is an accurate electronic urine-measuring device that combines an innovative disposable collection unit with a re-usable automatic electronic meter to provide precise urine monitoring. The UREXACT 2000 is based on the ultrasonic method of measuring fluid flow.
- Thus, although specific features of the invention are shown in some drawings and not in others, this is for convenience only as each feature may be combined with any or all of the other features in accordance with the invention. The words “including”, “comprising”, “having”, and “with” as used herein are to be interpreted broadly and comprehensively and are not limited to any physical interconnection. Moreover, any embodiments disclosed in the subject application are not to be taken as the only possible embodiments. Other embodiments will occur to those skilled in the art and are within the following claims.
- In addition, any amendment presented during the prosecution of the patent application for this patent is not a disclaimer of any claim element presented in the application as filed: those skilled in the art cannot reasonably be expected to draft a claim that would literally encompass all possible equivalents, many equivalents will be unforeseeable at the time of the amendment and are beyond a fair interpretation of what is to be surrendered (if anything), the rationale underlying the amendment may bear no more than a tangential relation to many equivalents, and/or there are many other reasons the applicant can not be expected to describe certain insubstantial substitutes for any claim element amended.
Claims (16)
1. A fluid management system for a patient, the system comprising:
a console for mounting on an IV pole, the console including an input for setting a desired fluid balance for a set therapy duration;
a first attachment mechanism extending from the console for hanging a urine collection chamber;
a second attachment mechanism extending from the console for hanging a source of hydration fluid;
a weighing subsystem in the console responsive to the first attachment mechanism for weighing the patient's urine output collected in the urine collection chamber and responsive to the second attachment mechanism for weighing the source of hydration fluid;
an infusion pump integrated with the console and configured to pump hydration fluid from the source of hydration fluid into the patient; and
a controller in the console, responsive to the set desired fluid balance, the set therapy duration, and the weighing subsystem, the controller configured to:
determine the patient's urine output based on the weight of the urine collection chamber,
determine the amount of fluid infused into the patient, and
control the infusion pump to inject hydration fluid into the patient based on the set desired fluid balance, the weight of the urine collection chamber, and the weight of the source of hydration fluid to achieve the desired fluid balance during the set therapy duration.
2. The system of claim 1 in which the console includes a display which displays the elapsed time of the therapy duration and the current fluid balance.
3. The system of claim 1 further including means for indicating, on the console, when the urine collection chamber is empty.
4. The system of claim 1 further including means for indicating, on the console, when the source of hydration fluid is low on fluid.
5. The system of claim 1 in which the controller is configured to determine the patient's urine output based on the rate of change of the weight of the urine collection chamber, calculate a desired infusion rate based on the determined rate of change of the weight of the urine collection chamber and the set desired fluid balance, and control the infusion pump to hydrate the patient based at least on the calculated desired infusion rate.
6. A fluid management system for a patient, the system comprising:
a console including an input for setting a desired fluid balance;
a urine collection chamber;
a weighing device for weighing the patient's urine output collected in the urine collection chamber;
a source of hydration fluid;
a pump associated with the console and configured to pump hydration fluid form the source of hydration fluid into the patient; and
a controller in the console configured to:
determine the patient's urine output based on the weight of the urine collection chamber,
operate the pump,
monitor the amount of hydration fluid injected into the patient based, and
control the pump based on the set desired fluid balance, the amount of hydration fluid injected into the patient, and the determined patient urine output.
7. A fluid management system for a patient, the system comprising:
a console for mounting on an IV pole, the console including an input for setting a desired fluid balance;
a first attachment mechanism extending from the console for handing a urine collection chamber;
a weighing device in the console responsive to the first attachment mechanism for weighing the patient's urine output collected in the urine collection chamber;
a controllable infusion pump integrated with the console and configured to pump hydration fluid from a source of hydration fluid into the patient at a variable rate; and
a controller in the console, responsive to the set desired fluid balance and the weighing device, the controller configured to:
determine the patient's urine output based on the rate of change of the weight of the urine collection chamber,
calculate a desired infusion rate based on the determined rate of change of the weight of the urine collection chamber and the set desired fluid balance, and
control the infusion pump to hydrate the patient based at least on the calculated desired infusion rate.
8. A method of addressing contrast induced nephropathy, the method comprising:
injecting a contrast agent into a patient;
imaging the patient; and
including diuresis to drive any contrast agent through the patient's kidneys to reduce its toxic effects on the kidneys and prevent damage to the kidneys by:
setting a desired fluid balance,
collecting urine expelled by the patient in a urine collection bag,
weighing the urine collection bag,
employing a pump to infuse the patient with fluid from a fluid source,
weighing the fluid source, and
automatically adjusting the pump based on the weight of the urine collection bag and the weight of the fluid source and controlling the amount of fluid infused into the patient based on the amount of urine expelled by the patient and the set desired fluid balance.
9. The method of claim 8 further including the step of administering a diuretic to the patient.
10. The method of claim 8 in which collecting urine expelled by the patient includes catheterizing the patient.
11. The method of claim 10 in which catheterizing the patient includes inserting a urinary catheter in the urinary tract of the patient.
12. The method of claim 8 in which weighing the urine collection bag includes providing an indication when a urine collection bag has reached its capacity.
13. The method of claim 8 in which weighing the fluid source includes providing an indication when the fluid source is low on fluid.
14. A method of addressing contrast induced nephropathy for a patient who has had a contrast agent injected into the patient, the method comprising:
collecting urine expelled by the patient;
determining the amount of urine expelled by the patient based on the collected urine;
infusing the patient with fluid from a fluid source;
determining the amount of fluid infused into the patient; and
inducing diuresis to dilute the concentration of any contrast agent in the patient by automatically adjusting the amount of fluid infused into the patient from the fluid source based on the determined amount of urine expelled by the patient to balance the amount of urine expelled by the patient with the amount of fluid infused into the patient.
15. A method of driving a toxin through a patient's kidneys, the method comprising:
collecting urine expelled by the patient;
determining the amount of urine expelled by the patient based on the collected urine;
infusing the patient with fluid from a fluid source;
determining the amount of fluid infused into the patient; and
inducing diuresis by automatically adjusting the amount of fluid infused into the patient from the fluid source based on the determined amount of urine expelled by the patient to balance the amount of urine expelled by the patient with the amount of fluid infused into the patient.
16. A method of preventing kidney damage due to dehydration, the method comprising:
collecting urine expelled by the patient;
determining the amount of urine expelled by the patient based on the collected urine;
infusing the patient with fluid from a fluid source;
determining the amount of fluid infused into the patient; and
maintaining the patient's hydration level by automatically adjusting the amount of fluid infused into the patient from the fluid source based on the determined amount of urine expelled by the patient to balance the amount of urine expelled by the patient with the amount of fluid infused into the patient;
increasing the patient's level of hydration by infusing additional fluid based on user settings over and above fluid infused to match the patient's urine output.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/798,940 US20100204677A1 (en) | 2004-09-09 | 2010-04-13 | Patient hydration system and method |
US13/507,234 US20120259309A1 (en) | 2004-09-09 | 2012-06-14 | Kidney protection method |
US13/507,233 US20120259308A1 (en) | 2004-09-09 | 2012-06-14 | Goal-directed fluid therapy |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/936,945 US7938817B2 (en) | 2004-09-09 | 2004-09-09 | Patient hydration system and method |
US12/798,940 US20100204677A1 (en) | 2004-09-09 | 2010-04-13 | Patient hydration system and method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/936,945 Division US7938817B2 (en) | 2004-09-09 | 2004-09-09 | Patient hydration system and method |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/507,233 Division US20120259308A1 (en) | 2004-09-09 | 2012-06-14 | Goal-directed fluid therapy |
US13/507,234 Division US20120259309A1 (en) | 2004-09-09 | 2012-06-14 | Kidney protection method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100204677A1 true US20100204677A1 (en) | 2010-08-12 |
Family
ID=35997207
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/936,945 Active 2029-03-15 US7938817B2 (en) | 2004-09-09 | 2004-09-09 | Patient hydration system and method |
US12/798,940 Abandoned US20100204677A1 (en) | 2004-09-09 | 2010-04-13 | Patient hydration system and method |
US13/507,233 Abandoned US20120259308A1 (en) | 2004-09-09 | 2012-06-14 | Goal-directed fluid therapy |
US13/507,234 Abandoned US20120259309A1 (en) | 2004-09-09 | 2012-06-14 | Kidney protection method |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/936,945 Active 2029-03-15 US7938817B2 (en) | 2004-09-09 | 2004-09-09 | Patient hydration system and method |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/507,233 Abandoned US20120259308A1 (en) | 2004-09-09 | 2012-06-14 | Goal-directed fluid therapy |
US13/507,234 Abandoned US20120259309A1 (en) | 2004-09-09 | 2012-06-14 | Kidney protection method |
Country Status (6)
Country | Link |
---|---|
US (4) | US7938817B2 (en) |
EP (1) | EP1804889B1 (en) |
JP (1) | JP4782134B2 (en) |
CA (1) | CA2579829C (en) |
ES (1) | ES2527442T3 (en) |
WO (1) | WO2006031249A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8444623B2 (en) | 2004-09-09 | 2013-05-21 | Plc Medical Systems, Inc. | Patient hydration method |
CN107715234A (en) * | 2017-08-29 | 2018-02-23 | 深圳市宏鑫源投资咨询有限公司 | Automatic alarm for infusion method and device |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7727222B2 (en) * | 2004-09-09 | 2010-06-01 | Plc Medical Systems, Inc. | Patient hydration system with taper down feature |
US7938817B2 (en) * | 2004-09-09 | 2011-05-10 | Plc Medical Systems, Inc. | Patient hydration system and method |
US7758563B2 (en) | 2004-09-09 | 2010-07-20 | Plc Medical Systems, Inc. | Patient hydration monitoring and maintenance system and method for use with administration of a diuretic |
US7837667B2 (en) * | 2004-09-09 | 2010-11-23 | Plc Medical Systems, Inc. | Patient hydration system with abnormal condition sensing |
US7736354B2 (en) * | 2004-09-09 | 2010-06-15 | Plc Medical Systems, Inc. | Patient hydration system with hydration state detection |
US11213621B2 (en) | 2004-09-09 | 2022-01-04 | Reprieve Cardiovascular, Inc. | Fluid therapy method |
EP2990073B1 (en) | 2004-11-24 | 2018-05-02 | Bayer Healthcare LLC | Devices and systems for fluid delivery |
US8556846B2 (en) * | 2005-07-28 | 2013-10-15 | Gambro Uf Solutions, Inc. | Blood volume controller during fluid removal |
US20070088333A1 (en) * | 2005-10-13 | 2007-04-19 | G&L Consulting, Llc | Method and system for infusing an osmotic solute into a patient and providing feedback control of the infusing rate |
KR100810075B1 (en) * | 2006-06-21 | 2008-03-07 | 부산대학교 산학협력단 | Monitoring system using an urine mass measuring sensor |
US8057454B2 (en) | 2006-08-25 | 2011-11-15 | Kimberly-Clark Worldwide, Inc. | Systems and methods for hydration sensing and monitoring |
US8075513B2 (en) * | 2006-10-13 | 2011-12-13 | Plc Medical Systems, Inc. | Patient connection system for a balance hydration unit |
JP5028067B2 (en) * | 2006-10-31 | 2012-09-19 | 株式会社テクトロン | Infusion supply system and infusion supply device |
AU2007320718A1 (en) * | 2006-11-14 | 2008-05-22 | Flowsense Ltd | A diagnostic method and apparatus |
WO2008085421A2 (en) | 2006-12-29 | 2008-07-17 | Medrad, Inc. | Patient-based parameter generation systems for medical injection procedures |
US7879020B1 (en) * | 2007-03-19 | 2011-02-01 | The United States Of America As Represented By The Secretary Of The Army | Decision-assist method for resuscitation of patients |
CN103976736B (en) | 2007-07-17 | 2017-01-11 | 拜耳医药保健有限责任公司 | Devices and systems for determination of parameters for a procedure, for estimation of cardiopulmonary function and for fluid delivery |
JP4976232B2 (en) * | 2007-08-22 | 2012-07-18 | アトムメディカル株式会社 | Incubator with built-in resuscitation treatment timer, incubator with resuscitation treatment timer and resuscitation treatment timer |
US20090062729A1 (en) * | 2007-09-01 | 2009-03-05 | Sang Hoon Woo | Controlling body fluid condition using diuretics |
US9421330B2 (en) | 2008-11-03 | 2016-08-23 | Bayer Healthcare Llc | Mitigation of contrast-induced nephropathy |
JP5356838B2 (en) * | 2009-01-20 | 2013-12-04 | 株式会社日立製作所 | Automatic urine collecting device |
US10045734B2 (en) * | 2009-01-28 | 2018-08-14 | Plc Medical Systems, Inc. | Fluid replacement device |
EP2295097A1 (en) | 2009-09-09 | 2011-03-16 | Fresenius Medical Care Deutschland GmbH | Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient |
GB201001069D0 (en) * | 2010-01-22 | 2010-03-10 | Ucl Business Plc | Method and apparatus for providing hydration fluid |
CA2803169C (en) | 2010-06-24 | 2020-09-22 | Medrad, Inc. | Modeling of pharmaceutical propagation and parameter generation for injection protocols |
WO2012006625A2 (en) | 2010-07-09 | 2012-01-12 | Velomedix, Inc. | Method and apparatus for pressure measurement |
WO2012033906A2 (en) | 2010-09-09 | 2012-03-15 | University Of Florida Research Foundation Inc. | Context-sensitive flow interrupter and drainage outflow optimization system |
KR20120052039A (en) * | 2010-11-15 | 2012-05-23 | 김성근 | Apparatus and method of controlling infusion pump using urine output |
US20120277155A1 (en) | 2011-02-25 | 2012-11-01 | Medtronic, Inc. | Therapy for kidney disease and/or heart failure |
EP2683422B1 (en) | 2011-03-07 | 2019-05-08 | Potrero Medical, Inc. | Sensing foley catheter |
US9211400B2 (en) * | 2011-07-18 | 2015-12-15 | Empi, Inc. | Electrodes, electrode systems, and methods of manufacture |
EP2750697A4 (en) | 2011-09-02 | 2015-03-25 | Medtronic Inc | Chimeric natriuretic peptide compositions and methods of preparation |
US20140031787A1 (en) * | 2012-04-13 | 2014-01-30 | Medtronic, Inc. | Feedback-based diuretic or natriuretic molecule administration |
US20130274705A1 (en) * | 2012-04-13 | 2013-10-17 | Medtronic, Inc. | Feedback-based diuretic or natriuretic molecule administration |
HUE056182T2 (en) | 2012-05-14 | 2022-01-28 | Bayer Healthcare Llc | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
JPWO2014049656A1 (en) * | 2012-09-27 | 2016-08-18 | テルモ株式会社 | Infusion pump |
ES2629038T3 (en) | 2013-03-15 | 2017-08-07 | Gambro Lundia Ab | Device for extracorporeal blood treatment with tank status lights |
WO2015105916A1 (en) | 2014-01-07 | 2015-07-16 | Consano, Inc. | Systems, devices and methods for draining and analyzing bodily fluids |
EP4108171A1 (en) * | 2014-03-17 | 2022-12-28 | Reprieve Cardiovascular, Inc. | Fluid therapy system |
AU2015236545B2 (en) * | 2014-03-24 | 2019-05-16 | Pepsico, Inc. | Hydration monitoring system |
WO2015192108A1 (en) * | 2014-06-12 | 2015-12-17 | Kostov Konstantin | Device and method for monitoring irregular liquid flow rates |
AU2015319822B2 (en) * | 2014-09-28 | 2020-07-23 | Potrero Medical, Inc. | Systems, devices and methods for sensing physiologic data and draining and analyzing bodily fluids |
JP6423750B2 (en) * | 2015-04-13 | 2018-11-14 | 公益財団法人ヒューマンサイエンス振興財団 | Beverages or jellies to prevent the occurrence of contrast media nephropathy |
US11541205B2 (en) | 2015-07-20 | 2023-01-03 | Roivios Limited | Coated urinary catheter or ureteral stent and method |
US11040180B2 (en) | 2015-07-20 | 2021-06-22 | Strataca Systems Limited | Systems, kits and methods for inducing negative pressure to increase renal function |
CN108136163B (en) | 2015-07-20 | 2021-05-04 | 斯卓特凯系统有限责任公司 | Ureteral and bladder catheters and methods of introducing negative pressure to increase renal perfusion |
US10765834B2 (en) | 2015-07-20 | 2020-09-08 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
US10512713B2 (en) | 2015-07-20 | 2019-12-24 | Strataca Systems Limited | Method of removing excess fluid from a patient with hemodilution |
US11229771B2 (en) | 2015-07-20 | 2022-01-25 | Roivios Limited | Percutaneous ureteral catheter |
US11040172B2 (en) | 2015-07-20 | 2021-06-22 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
US10918827B2 (en) | 2015-07-20 | 2021-02-16 | Strataca Systems Limited | Catheter device and method for inducing negative pressure in a patient's bladder |
US10493232B2 (en) | 2015-07-20 | 2019-12-03 | Strataca Systems Limited | Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function |
US10926062B2 (en) | 2015-07-20 | 2021-02-23 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
US10391275B2 (en) | 2015-11-17 | 2019-08-27 | Potrero Medical, Inc. | Systems, devices and methods for draining and analyzing bodily fluids |
JP2017153920A (en) * | 2016-02-29 | 2017-09-07 | 直人 久保田 | Suspension stand of urine sampling/urine collection bags capable of being disassembled/assembled, height adjustable and portable |
US20210085853A1 (en) * | 2018-03-01 | 2021-03-25 | University Of Washington | Systems and methods for automated assessment and monitoring of bodily fluids |
EP3794603A2 (en) * | 2018-05-18 | 2021-03-24 | Reprieve Cardiovascular, Inc. | Method and system to treat acute decompensated heart failure |
CN109259728A (en) * | 2018-09-14 | 2019-01-25 | 孟祥宝 | A kind of body metabolism monitoring system recorded in real time based on amount of infusion and amount of urine |
EP3753492A1 (en) | 2019-06-17 | 2020-12-23 | Diuriflux Medical SA | Body fluid meter assembly, in particular for measuring diuresis |
EP4070325A1 (en) * | 2019-12-06 | 2022-10-12 | Reprieve Cardiovascular, Inc. | Managing fluid levels in a patient and associated devices, systems, and methods |
CN112972814A (en) * | 2021-01-28 | 2021-06-18 | 青岛大学附属医院 | Old patient rehabilitation and nursing device |
CN113100770B (en) * | 2021-04-12 | 2022-08-30 | 中国人民解放军陆军特色医学中心 | Abdominal cavity pressure measuring equipment |
CN116173346B (en) * | 2023-03-01 | 2023-08-15 | 北京哈特凯尔医疗科技有限公司 | Hydration treatment device |
Citations (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3954010A (en) * | 1975-04-25 | 1976-05-04 | Illinois Tool Works Inc. | Visual and electronic battery hydrometer |
US4132644A (en) * | 1977-06-28 | 1979-01-02 | A/S Nycotron | Means for regulating and monitoring dialysis of blood in a dialyzer |
US4146029A (en) * | 1974-04-23 | 1979-03-27 | Ellinwood Jr Everett H | Self-powered implanted programmable medication system and method |
US4204957A (en) * | 1975-11-21 | 1980-05-27 | Sartorius Membranfilter Gmbh | Artificial kidney |
US4216462A (en) * | 1978-03-06 | 1980-08-05 | General Electric Company | Patient monitoring and data processing system |
US4229299A (en) * | 1978-03-22 | 1980-10-21 | Hoechst Aktiengesellschaft | Peristaltic dialysate solution pump |
US4261360A (en) * | 1979-11-05 | 1981-04-14 | Urethral Devices Research, Inc. | Transurethral irrigation pressure controller |
US4275726A (en) * | 1977-12-09 | 1981-06-30 | Dr. Eduard Fresenius, Chemisch-Pharmazeutische Industrie Kg Apparatebau Kg | Apparatus for fluid balancing under sterile conditions |
US4291692A (en) * | 1979-10-09 | 1981-09-29 | University Of Utah | Closed-loop infusion system, both method and apparatus, based on real time urine measurement |
US4343316A (en) * | 1980-05-16 | 1982-08-10 | C. R. Bard, Inc. | Electronic urine flow monitor |
US4448207A (en) * | 1981-11-03 | 1984-05-15 | Vital Metrics, Inc. | Medical fluid measuring system |
US4449538A (en) * | 1982-01-25 | 1984-05-22 | John Corbitt | Medical-electronic body fluid accounting system |
US4458562A (en) * | 1982-06-16 | 1984-07-10 | Interstate Exploration, Inc. | Rod wrench |
US4504263A (en) * | 1982-12-22 | 1985-03-12 | Valleylab, Inc. | Flow rate monitor with optical sensing chamber |
US4658834A (en) * | 1983-03-16 | 1987-04-21 | C.R. Bard, Inc. | Medical apparatus for monitoring body liquid discharge |
US4712567A (en) * | 1985-03-14 | 1987-12-15 | American Hospital Supply Corporation | Liquid meter assembly |
US4728433A (en) * | 1984-02-02 | 1988-03-01 | Cd Medical, Inc. | Ultrafiltration regulation by differential weighing |
US4813925A (en) * | 1987-04-21 | 1989-03-21 | Medical Engineering Corporation | Spiral ureteral stent |
US4923598A (en) * | 1987-06-23 | 1990-05-08 | Fresenius Ag | Apparatus for the treatment of blood in particular for hemodialysis and hemofiltration |
US4994026A (en) * | 1988-08-31 | 1991-02-19 | W. R. Grace & Co.-Conn. | Gravity flow fluid balance system |
US5098379A (en) * | 1990-01-10 | 1992-03-24 | Rochester Medical Corporation | Catheter having lubricated outer sleeve and methods for making and using same |
US5176148A (en) * | 1989-09-30 | 1993-01-05 | Friedhelm M. West | Device for measuring the urine flow (uroflow) of patient |
US5207642A (en) * | 1987-08-07 | 1993-05-04 | Baxter International Inc. | Closed multi-fluid delivery system and method |
US5573506A (en) * | 1994-11-25 | 1996-11-12 | Block Medical, Inc. | Remotely programmable infusion system |
US5722947A (en) * | 1994-02-03 | 1998-03-03 | Gambro Ab | Apparatus for carrying out peritoneal dialyses |
US5769087A (en) * | 1993-11-12 | 1998-06-23 | Fresenius Ag | Urine measurement apparatus and method for the determination of the density of urine |
US5814009A (en) * | 1996-10-11 | 1998-09-29 | Cabot Technology Corporation | Fluid management system and replaceable tubing assembly therefor |
US5891051A (en) * | 1995-06-02 | 1999-04-06 | C.R. Bard, Inc. | Electronic urine monitor |
US5910252A (en) * | 1993-02-12 | 1999-06-08 | Cobe Laboratories, Inc. | Technique for extracorporeal treatment of blood |
US5916195A (en) * | 1998-02-04 | 1999-06-29 | Argomed Ltd. | Internal catheter |
US5916153A (en) * | 1997-10-27 | 1999-06-29 | Rhea, Jr.; W. Gardner | Multifunction catheter |
US5981051A (en) * | 1995-08-31 | 1999-11-09 | Idemitsu Petrochemical Co., Ltd. | Method for producing granular polycarbonate prepolymer for solid-state polymerization |
US6010454A (en) * | 1997-05-29 | 2000-01-04 | Aquintel, Inc. | Fluid and electrolyte balance monitoring system for surgical and critically ill patients |
US6171253B1 (en) * | 1999-05-04 | 2001-01-09 | Apex Medical, Inc. | Flat tube pressure sensor |
US6231551B1 (en) * | 1999-03-01 | 2001-05-15 | Coaxia, Inc. | Partial aortic occlusion devices and methods for cerebral perfusion augmentation |
US6272930B1 (en) * | 1996-05-10 | 2001-08-14 | Corneal Industrie | Tube assembly including a pressure measuring device |
US20020025597A1 (en) * | 1998-11-19 | 2002-02-28 | Kenichi Matsuda | Semiconductor device and method for producing the same |
US20020072647A1 (en) * | 2000-12-12 | 2002-06-13 | Schock Robert B. | Intra-aortic balloon catheter having a dual sensor pressure sensing system |
US20020107536A1 (en) * | 2001-02-07 | 2002-08-08 | Hussein Hany M. | Device and method for preventing kidney failure |
US20020151834A1 (en) * | 1996-09-23 | 2002-10-17 | Utterberg David S. | Blood set priming method and apparatus |
US20020161314A1 (en) * | 2000-02-17 | 2002-10-31 | Malla Sarajarvi | Arrangement for patient monitor |
US6514226B1 (en) * | 2000-02-10 | 2003-02-04 | Chf Solutions, Inc. | Method and apparatus for treatment of congestive heart failure by improving perfusion of the kidney |
US6531551B2 (en) * | 1996-08-09 | 2003-03-11 | Chisso Corporation | Polypropylene composition, process for preparing the same, and polymerization catalyst therefor |
US20030048432A1 (en) * | 1998-08-27 | 2003-03-13 | Tzyy-Wen Jeng | Reagentless analysis of biological samples |
US20030048185A1 (en) * | 2001-09-07 | 2003-03-13 | Citrenbaum, M.D. Richard A. | Apparatus and process for infusion monitoring |
US6537244B2 (en) * | 1999-01-19 | 2003-03-25 | Assistive Technology Products, Inc. | Methods and apparatus for delivering fluids |
US6554791B1 (en) * | 1999-09-29 | 2003-04-29 | Smisson-Cartledge Biomedical, Llc | Rapid infusion system |
US20030114786A1 (en) * | 2000-03-09 | 2003-06-19 | Joachim Hiller | Fluid counterbalancing system |
US6640649B1 (en) * | 1999-01-14 | 2003-11-04 | S.F.M. Sophisticated Flow Meters Ltd. | Droplet counter for low flow rates |
US20040025597A1 (en) * | 2000-04-19 | 2004-02-12 | Bjorn Ericson | Method and device for monitoring the flow speed of an infusion solution |
US20040081585A1 (en) * | 2001-02-22 | 2004-04-29 | Brian Reid | Device and method for measuring urine conductivity |
US20040087894A1 (en) * | 2000-09-08 | 2004-05-06 | Flaherty J. Christopher | Devices, systems and methods for patient infusion |
US6740072B2 (en) * | 2001-09-07 | 2004-05-25 | Medtronic Minimed, Inc. | System and method for providing closed loop infusion formulation delivery |
US20040122353A1 (en) * | 2002-12-19 | 2004-06-24 | Medtronic Minimed, Inc. | Relay device for transferring information between a sensor system and a fluid delivery system |
US20040133187A1 (en) * | 2002-10-03 | 2004-07-08 | Scott Laboratories, Inc. | Methods and systems for providing orthogonally redundant monitoring in a sedation and analgesia system |
US20040167415A1 (en) * | 2003-02-24 | 2004-08-26 | Plc Systems Inc. | Method and system for prevention of radiocontrast nephropathy |
US20040167464A1 (en) * | 2002-07-24 | 2004-08-26 | Medtronic Minimed, Inc. | Physiological monitoring device for controlling a medication infusion device |
US20040176703A1 (en) * | 2003-03-04 | 2004-09-09 | Christensen Mark C. | Apparatus for monitoring intra-abdominal pressure |
US6796960B2 (en) * | 2001-05-04 | 2004-09-28 | Wit Ip Corporation | Low thermal resistance elastic sleeves for medical device balloons |
US20040193328A1 (en) * | 2000-05-26 | 2004-09-30 | Terumo Kabushiki Kaisha | Medical pump monitoring system |
US20040243075A1 (en) * | 2002-02-26 | 2004-12-02 | Harvie Mark R. | Automatic self cleaning bladder relief system |
US6827702B2 (en) * | 2001-09-07 | 2004-12-07 | Medtronic Minimed, Inc. | Safety limits for closed-loop infusion pump control |
US20050027254A1 (en) * | 1994-11-25 | 2005-02-03 | Vasko Robert S. | Remotely programmable infusion system |
US20050065464A1 (en) * | 2002-07-24 | 2005-03-24 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
US20050085760A1 (en) * | 2003-10-15 | 2005-04-21 | Ware Lee C. | Medical fluid therapy flow balancing and synchronization system |
US20060052764A1 (en) * | 2004-09-09 | 2006-03-09 | Mark Gelfand | Patient hydration system and method |
US20060064053A1 (en) * | 2004-09-17 | 2006-03-23 | Bollish Stephen J | Multichannel coordinated infusion system |
US20060235353A1 (en) * | 2004-09-09 | 2006-10-19 | Mark Gelfand | Patient hydration system with abnormal condition sensing |
US20060253064A1 (en) * | 2004-09-09 | 2006-11-09 | Mark Gelfand | Patient hydration system with hydration state detection |
US20060270971A1 (en) * | 2004-09-09 | 2006-11-30 | Mark Gelfand | Patient hydration system with a redundant monitoring of hydration fluid infusion |
US20070088333A1 (en) * | 2005-10-13 | 2007-04-19 | G&L Consulting, Llc | Method and system for infusing an osmotic solute into a patient and providing feedback control of the infusing rate |
US7291692B2 (en) * | 2003-09-25 | 2007-11-06 | Sumitomo Chemical Company, Limited | Polyarylene oxide and method of producing the same |
US20080027409A1 (en) * | 2004-09-09 | 2008-01-31 | Rudko Robert I | Patient hydration/fluid administration system and method |
US20080033394A1 (en) * | 2004-09-09 | 2008-02-07 | Mark Gelfand | Patient hydration monitoring and maintenance system and method for use with administration of a diuretic |
US20080171966A1 (en) * | 2006-10-13 | 2008-07-17 | Rudko Robert I | Patient connection system for a balance hydration unit |
US20080221512A1 (en) * | 2004-09-09 | 2008-09-11 | Da Silva J Ricardo | Patient hydration system with taper down feature |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4343207A (en) * | 1980-02-04 | 1982-08-10 | Crutcher Corporation | Tool for spiral machining |
DE3629732A1 (en) | 1986-09-01 | 1988-03-03 | Franz Dr Med Heinz | BLADDER AND URINE PRESSURE CATHETER |
AU8616198A (en) * | 1997-08-01 | 1999-02-22 | Nova-Technik Entwicklung Von Und Handel mit Medizinischen Ge raten GmbH | Installation and device for regulating fluid equilibrium in patients |
US8052671B2 (en) | 2004-10-11 | 2011-11-08 | Abviser Medical, Llc | Intra-abdominal pressure monitoring device and method |
-
2004
- 2004-09-09 US US10/936,945 patent/US7938817B2/en active Active
-
2005
- 2005-03-18 JP JP2007531154A patent/JP4782134B2/en active Active
- 2005-03-18 EP EP05728355.8A patent/EP1804889B1/en active Active
- 2005-03-18 WO PCT/US2005/008948 patent/WO2006031249A2/en active Application Filing
- 2005-03-18 CA CA002579829A patent/CA2579829C/en active Active
- 2005-03-18 ES ES05728355.8T patent/ES2527442T3/en active Active
-
2010
- 2010-04-13 US US12/798,940 patent/US20100204677A1/en not_active Abandoned
-
2012
- 2012-06-14 US US13/507,233 patent/US20120259308A1/en not_active Abandoned
- 2012-06-14 US US13/507,234 patent/US20120259309A1/en not_active Abandoned
Patent Citations (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4146029A (en) * | 1974-04-23 | 1979-03-27 | Ellinwood Jr Everett H | Self-powered implanted programmable medication system and method |
US3954010A (en) * | 1975-04-25 | 1976-05-04 | Illinois Tool Works Inc. | Visual and electronic battery hydrometer |
US4204957A (en) * | 1975-11-21 | 1980-05-27 | Sartorius Membranfilter Gmbh | Artificial kidney |
US4132644A (en) * | 1977-06-28 | 1979-01-02 | A/S Nycotron | Means for regulating and monitoring dialysis of blood in a dialyzer |
US4275726A (en) * | 1977-12-09 | 1981-06-30 | Dr. Eduard Fresenius, Chemisch-Pharmazeutische Industrie Kg Apparatebau Kg | Apparatus for fluid balancing under sterile conditions |
US4216462A (en) * | 1978-03-06 | 1980-08-05 | General Electric Company | Patient monitoring and data processing system |
US4229299A (en) * | 1978-03-22 | 1980-10-21 | Hoechst Aktiengesellschaft | Peristaltic dialysate solution pump |
US4291692A (en) * | 1979-10-09 | 1981-09-29 | University Of Utah | Closed-loop infusion system, both method and apparatus, based on real time urine measurement |
US4261360A (en) * | 1979-11-05 | 1981-04-14 | Urethral Devices Research, Inc. | Transurethral irrigation pressure controller |
US4343316A (en) * | 1980-05-16 | 1982-08-10 | C. R. Bard, Inc. | Electronic urine flow monitor |
US4448207A (en) * | 1981-11-03 | 1984-05-15 | Vital Metrics, Inc. | Medical fluid measuring system |
US4449538A (en) * | 1982-01-25 | 1984-05-22 | John Corbitt | Medical-electronic body fluid accounting system |
US4458562A (en) * | 1982-06-16 | 1984-07-10 | Interstate Exploration, Inc. | Rod wrench |
US4504263A (en) * | 1982-12-22 | 1985-03-12 | Valleylab, Inc. | Flow rate monitor with optical sensing chamber |
US4658834A (en) * | 1983-03-16 | 1987-04-21 | C.R. Bard, Inc. | Medical apparatus for monitoring body liquid discharge |
US4728433A (en) * | 1984-02-02 | 1988-03-01 | Cd Medical, Inc. | Ultrafiltration regulation by differential weighing |
US4712567A (en) * | 1985-03-14 | 1987-12-15 | American Hospital Supply Corporation | Liquid meter assembly |
US4813925A (en) * | 1987-04-21 | 1989-03-21 | Medical Engineering Corporation | Spiral ureteral stent |
US4923598A (en) * | 1987-06-23 | 1990-05-08 | Fresenius Ag | Apparatus for the treatment of blood in particular for hemodialysis and hemofiltration |
US5207642A (en) * | 1987-08-07 | 1993-05-04 | Baxter International Inc. | Closed multi-fluid delivery system and method |
US4994026A (en) * | 1988-08-31 | 1991-02-19 | W. R. Grace & Co.-Conn. | Gravity flow fluid balance system |
US5176148A (en) * | 1989-09-30 | 1993-01-05 | Friedhelm M. West | Device for measuring the urine flow (uroflow) of patient |
US5098379A (en) * | 1990-01-10 | 1992-03-24 | Rochester Medical Corporation | Catheter having lubricated outer sleeve and methods for making and using same |
US5910252A (en) * | 1993-02-12 | 1999-06-08 | Cobe Laboratories, Inc. | Technique for extracorporeal treatment of blood |
US5769087A (en) * | 1993-11-12 | 1998-06-23 | Fresenius Ag | Urine measurement apparatus and method for the determination of the density of urine |
US5722947A (en) * | 1994-02-03 | 1998-03-03 | Gambro Ab | Apparatus for carrying out peritoneal dialyses |
US5573506A (en) * | 1994-11-25 | 1996-11-12 | Block Medical, Inc. | Remotely programmable infusion system |
US20050027254A1 (en) * | 1994-11-25 | 2005-02-03 | Vasko Robert S. | Remotely programmable infusion system |
US5891051A (en) * | 1995-06-02 | 1999-04-06 | C.R. Bard, Inc. | Electronic urine monitor |
US5981051A (en) * | 1995-08-31 | 1999-11-09 | Idemitsu Petrochemical Co., Ltd. | Method for producing granular polycarbonate prepolymer for solid-state polymerization |
US6272930B1 (en) * | 1996-05-10 | 2001-08-14 | Corneal Industrie | Tube assembly including a pressure measuring device |
US6531551B2 (en) * | 1996-08-09 | 2003-03-11 | Chisso Corporation | Polypropylene composition, process for preparing the same, and polymerization catalyst therefor |
US20020151834A1 (en) * | 1996-09-23 | 2002-10-17 | Utterberg David S. | Blood set priming method and apparatus |
US5814009A (en) * | 1996-10-11 | 1998-09-29 | Cabot Technology Corporation | Fluid management system and replaceable tubing assembly therefor |
US6010454A (en) * | 1997-05-29 | 2000-01-04 | Aquintel, Inc. | Fluid and electrolyte balance monitoring system for surgical and critically ill patients |
US5916153A (en) * | 1997-10-27 | 1999-06-29 | Rhea, Jr.; W. Gardner | Multifunction catheter |
US5916195A (en) * | 1998-02-04 | 1999-06-29 | Argomed Ltd. | Internal catheter |
US20030048432A1 (en) * | 1998-08-27 | 2003-03-13 | Tzyy-Wen Jeng | Reagentless analysis of biological samples |
US20020025597A1 (en) * | 1998-11-19 | 2002-02-28 | Kenichi Matsuda | Semiconductor device and method for producing the same |
US6640649B1 (en) * | 1999-01-14 | 2003-11-04 | S.F.M. Sophisticated Flow Meters Ltd. | Droplet counter for low flow rates |
US6752779B2 (en) * | 1999-01-19 | 2004-06-22 | Assistive Technology Products, Inc. | Methods and apparatus for delivering fluids |
US6537244B2 (en) * | 1999-01-19 | 2003-03-25 | Assistive Technology Products, Inc. | Methods and apparatus for delivering fluids |
US6231551B1 (en) * | 1999-03-01 | 2001-05-15 | Coaxia, Inc. | Partial aortic occlusion devices and methods for cerebral perfusion augmentation |
US6171253B1 (en) * | 1999-05-04 | 2001-01-09 | Apex Medical, Inc. | Flat tube pressure sensor |
US6554791B1 (en) * | 1999-09-29 | 2003-04-29 | Smisson-Cartledge Biomedical, Llc | Rapid infusion system |
US20040059295A1 (en) * | 1999-09-29 | 2004-03-25 | Smisson-Cartledge Biomedical Llc | Rapid infusion system |
US6942637B2 (en) * | 1999-09-29 | 2005-09-13 | Smisson-Cartledge Biomedical Llc | Rapid infusion system |
US6514226B1 (en) * | 2000-02-10 | 2003-02-04 | Chf Solutions, Inc. | Method and apparatus for treatment of congestive heart failure by improving perfusion of the kidney |
US20020161314A1 (en) * | 2000-02-17 | 2002-10-31 | Malla Sarajarvi | Arrangement for patient monitor |
US20030114786A1 (en) * | 2000-03-09 | 2003-06-19 | Joachim Hiller | Fluid counterbalancing system |
US20040025597A1 (en) * | 2000-04-19 | 2004-02-12 | Bjorn Ericson | Method and device for monitoring the flow speed of an infusion solution |
US7044002B2 (en) * | 2000-04-19 | 2006-05-16 | Ganbro Lundia Ab | Method and device for monitoring the flow speed of an infusion solution |
US20040193328A1 (en) * | 2000-05-26 | 2004-09-30 | Terumo Kabushiki Kaisha | Medical pump monitoring system |
US20040087894A1 (en) * | 2000-09-08 | 2004-05-06 | Flaherty J. Christopher | Devices, systems and methods for patient infusion |
US7137964B2 (en) * | 2000-09-08 | 2006-11-21 | Insulet Corporation | Devices, systems and methods for patient infusion |
US20020072647A1 (en) * | 2000-12-12 | 2002-06-13 | Schock Robert B. | Intra-aortic balloon catheter having a dual sensor pressure sensing system |
US20020107536A1 (en) * | 2001-02-07 | 2002-08-08 | Hussein Hany M. | Device and method for preventing kidney failure |
US20040081585A1 (en) * | 2001-02-22 | 2004-04-29 | Brian Reid | Device and method for measuring urine conductivity |
US6796960B2 (en) * | 2001-05-04 | 2004-09-28 | Wit Ip Corporation | Low thermal resistance elastic sleeves for medical device balloons |
US6740072B2 (en) * | 2001-09-07 | 2004-05-25 | Medtronic Minimed, Inc. | System and method for providing closed loop infusion formulation delivery |
US20030048185A1 (en) * | 2001-09-07 | 2003-03-13 | Citrenbaum, M.D. Richard A. | Apparatus and process for infusion monitoring |
US6827702B2 (en) * | 2001-09-07 | 2004-12-07 | Medtronic Minimed, Inc. | Safety limits for closed-loop infusion pump control |
US20040243075A1 (en) * | 2002-02-26 | 2004-12-02 | Harvie Mark R. | Automatic self cleaning bladder relief system |
US20050065464A1 (en) * | 2002-07-24 | 2005-03-24 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
US20040167464A1 (en) * | 2002-07-24 | 2004-08-26 | Medtronic Minimed, Inc. | Physiological monitoring device for controlling a medication infusion device |
US7278983B2 (en) * | 2002-07-24 | 2007-10-09 | Medtronic Minimed, Inc. | Physiological monitoring device for controlling a medication infusion device |
US20040133187A1 (en) * | 2002-10-03 | 2004-07-08 | Scott Laboratories, Inc. | Methods and systems for providing orthogonally redundant monitoring in a sedation and analgesia system |
US20040122353A1 (en) * | 2002-12-19 | 2004-06-24 | Medtronic Minimed, Inc. | Relay device for transferring information between a sensor system and a fluid delivery system |
US20040163655A1 (en) * | 2003-02-24 | 2004-08-26 | Plc Systems Inc. | Method and catheter system applicable to acute renal failure |
US20040167415A1 (en) * | 2003-02-24 | 2004-08-26 | Plc Systems Inc. | Method and system for prevention of radiocontrast nephropathy |
US20040176703A1 (en) * | 2003-03-04 | 2004-09-09 | Christensen Mark C. | Apparatus for monitoring intra-abdominal pressure |
US7291692B2 (en) * | 2003-09-25 | 2007-11-06 | Sumitomo Chemical Company, Limited | Polyarylene oxide and method of producing the same |
US20050085760A1 (en) * | 2003-10-15 | 2005-04-21 | Ware Lee C. | Medical fluid therapy flow balancing and synchronization system |
US7029456B2 (en) * | 2003-10-15 | 2006-04-18 | Baxter International Inc. | Medical fluid therapy flow balancing and synchronization system |
US20060184084A1 (en) * | 2003-10-15 | 2006-08-17 | Ware Lee C | Medical fluid therapy flow balancing and synchronization method and apparatus |
US20060052764A1 (en) * | 2004-09-09 | 2006-03-09 | Mark Gelfand | Patient hydration system and method |
US20100280445A1 (en) * | 2004-09-09 | 2010-11-04 | Mark Gelfand | Patient hydration system with taper down function |
US20060270971A1 (en) * | 2004-09-09 | 2006-11-30 | Mark Gelfand | Patient hydration system with a redundant monitoring of hydration fluid infusion |
US7837667B2 (en) * | 2004-09-09 | 2010-11-23 | Plc Medical Systems, Inc. | Patient hydration system with abnormal condition sensing |
US20060235353A1 (en) * | 2004-09-09 | 2006-10-19 | Mark Gelfand | Patient hydration system with abnormal condition sensing |
US20100280443A1 (en) * | 2004-09-09 | 2010-11-04 | Mark Gelfand | Patient hydration system with redundant monitoring |
US20080027409A1 (en) * | 2004-09-09 | 2008-01-31 | Rudko Robert I | Patient hydration/fluid administration system and method |
US20080033394A1 (en) * | 2004-09-09 | 2008-02-07 | Mark Gelfand | Patient hydration monitoring and maintenance system and method for use with administration of a diuretic |
US20100280444A1 (en) * | 2004-09-09 | 2010-11-04 | Mark Gelfand | Patient hydration system with abnormal reading detection |
US20080221512A1 (en) * | 2004-09-09 | 2008-09-11 | Da Silva J Ricardo | Patient hydration system with taper down feature |
US7736354B2 (en) * | 2004-09-09 | 2010-06-15 | Plc Medical Systems, Inc. | Patient hydration system with hydration state detection |
US7758563B2 (en) * | 2004-09-09 | 2010-07-20 | Plc Medical Systems, Inc. | Patient hydration monitoring and maintenance system and method for use with administration of a diuretic |
US20100234797A1 (en) * | 2004-09-09 | 2010-09-16 | Mark Gelfand | Patient hydration system with bolus function |
US20060253064A1 (en) * | 2004-09-09 | 2006-11-09 | Mark Gelfand | Patient hydration system with hydration state detection |
US20060064053A1 (en) * | 2004-09-17 | 2006-03-23 | Bollish Stephen J | Multichannel coordinated infusion system |
US20070088333A1 (en) * | 2005-10-13 | 2007-04-19 | G&L Consulting, Llc | Method and system for infusing an osmotic solute into a patient and providing feedback control of the infusing rate |
US20080171966A1 (en) * | 2006-10-13 | 2008-07-17 | Rudko Robert I | Patient connection system for a balance hydration unit |
US8075513B2 (en) * | 2006-10-13 | 2011-12-13 | Plc Medical Systems, Inc. | Patient connection system for a balance hydration unit |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8444623B2 (en) | 2004-09-09 | 2013-05-21 | Plc Medical Systems, Inc. | Patient hydration method |
CN107715234A (en) * | 2017-08-29 | 2018-02-23 | 深圳市宏鑫源投资咨询有限公司 | Automatic alarm for infusion method and device |
Also Published As
Publication number | Publication date |
---|---|
CA2579829A1 (en) | 2006-03-23 |
WO2006031249A2 (en) | 2006-03-23 |
EP1804889B1 (en) | 2014-10-08 |
US20120259309A1 (en) | 2012-10-11 |
JP2008512179A (en) | 2008-04-24 |
WO2006031249A3 (en) | 2007-02-08 |
EP1804889A4 (en) | 2010-07-28 |
EP1804889A2 (en) | 2007-07-11 |
CA2579829C (en) | 2009-07-14 |
US20120259308A1 (en) | 2012-10-11 |
US20060052764A1 (en) | 2006-03-09 |
ES2527442T3 (en) | 2015-01-23 |
US7938817B2 (en) | 2011-05-10 |
JP4782134B2 (en) | 2011-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7938817B2 (en) | Patient hydration system and method | |
US7758563B2 (en) | Patient hydration monitoring and maintenance system and method for use with administration of a diuretic | |
US7727222B2 (en) | Patient hydration system with taper down feature | |
US20080027409A1 (en) | Patient hydration/fluid administration system and method | |
US8444623B2 (en) | Patient hydration method | |
US7837667B2 (en) | Patient hydration system with abnormal condition sensing | |
US7736354B2 (en) | Patient hydration system with hydration state detection | |
US10639419B2 (en) | Fluid therapy method | |
US20220152302A1 (en) | Fluid therapy method | |
EP2010251B1 (en) | Patient hydration system with abnormal condition sensing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |